MDT and BSX Related Headlines
Go Back- Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
- BofA’s six MedTech picks for 2026 on strong earnings growth
- Needham: 'we believe that the Section 232 investigation creates a new overhang for the already beleaguered medical device sector'
- Stifel: Electrophysiology Market Growth is Healthy
- Medtronic (MDT) gains on RDN NCA proposal
- Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings
